New home for BioFocus

BioFocus and Aviva Investors have signed an agreement for the construction of a new laboratory and HQ building at Chesterford Research Park.

The Robinson Building – a 60,000 square foot state-of-the-art laboratory facility – will unite the majority of BioFocus’ drug discovery groups.

“BioFocus has been expanding its research activities at Chesterford Park bringing our expertise in different areas such as structural biology, complex cells assays, and medicinal chemistry together,” said Chris Newton of BioFocus. “Moving many of these teams into a single, modern and efficient building in an important step forward for the company and will bring added synergies to both our business model and to our scientists.”

The building already has outline planning permission and construction is expected to start almost immediately. The building has been designed as two wings, linked by an impressive two-storey atrium and landscaped courtyard.”

Julian Cobourne, Asset manager for Aviva Investors said: “Chesterford Research Park has provided significant support to BioFocus in meeting its property needs over the years and it has been great to work with them to design a much moreefficient laboratory building to meet its requirements.”